Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study

Background: Few Saudi studies have examined adverse drug reactions (ADRs) in patients with rheumatoid arthritis (RA) receiving intravenous (IV) originator biologics. Therefore, this study aimed to evaluate the prevalence, types, and predictors of ADRs following long-term IV originator biologic use i...

Full description

Bibliographic Details

Published in:	Saudi Pharmaceutical Journal
Main Authors:	Haya M. Almalag, Shiekha S. Alaujan, Hawazin S. Alhazzani, Lamia A. Alzamel, Reem S. Tashkandi, Hussain F. Alarfaj, Abdurhman S. Alarfaj, Mohammed A. Omair
Format:	Article
Language:	English
Published:	Springer 2022-07-01
Subjects:	Intravenous biologics Adverse drug reactions Rheumatoid arthritis Naranjo scale
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016422001141